Ryan C. Lynch

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with Fred Hutch Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling”.

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling

Nature(2023)10.1038/s41586-023-06903-x

N/A

2.5DataRank · unranked

111 citations

Mohammad Shahrokh Esfahani, Andrea Garofalo, Michael Y. Li, Cédric Rossi, Tim Flerlage +44 more

Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study

The Lancet Haematology(2021)10.1016/s2352-3026(21)00170-8

N/A

1.6DataRank · unranked

59 citations

Ryan D. Cassaday, Stephen D. Smith, Jonathan R. Fromm, Andrew J. Cowan, Edus H. Warren +15 more

Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma

Blood(2023)10.1182/blood.2022019254

N/A

1.4DataRank · unranked

39 citations

Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman +21 more

Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study

Blood Advances(2024)10.1182/bloodadvances.2023011569

N/A

0.373DataRank · unranked

11 citations

Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen E. Spurgeon, Deborah M. Stephens +30 more

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

Blood Advances(2022)10.1182/bloodadvances.2022008628

N/A

0.240DataRank · unranked

3 citations

Ryan C. Lynch, Chaitra S. Ujjani, Ted Gooley, Heather Rasmussen, David G. Coffey +9 more

Long-term efficacy and safety of pembrolizumab with R-CHOP as first-line therapy for DLBCL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7561

N/A

0DataRank · unranked

1 citations

Jonathan R. Fromm, Min Fang, Brian G. Till, Mazyar Shadman, Andrew J. Cowan +11 more

tRNA ADENOSINE DEAMINASE 3 is required for telomere maintenance in Arabidopsis thaliana

Plant Cell Reports(2020)10.1007/s00299-020-02594-0

N/A

0DataRank · unranked

15 citations

Ana Victoria Suescún, Jiarui Song, Claudia Castillo-González, Behailu Birhanu Aklilu, Erica Branham +3 more

A phase 2 study of frontline pembrolizumab in follicular lymphoma

eJHaem(2024)10.1002/jha2.1029

N/A

0DataRank · unranked

0 citations

Songli Zhu, Ted Gooley, Taranjit S. Gujral, Ryan C. Lynch, Christina Poh +5 more

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Leukemia(2021)10.1038/s41375-021-01193-6

N/A

0DataRank · unranked

83 citations

Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.4304

N/A

0DataRank · unranked

72 citations

Sonya Reid, Benjamin French, Cassandra Hennessy, Clara Hwang, Na Tosha Gatson +95 more

Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium

The Lancet Healthy Longevity(2022)10.1016/s2666-7568(22)00009-5

N/A

0DataRank · unranked

22 citations

Cassandra Hennessy, Nicole M. Kuderer, Samuel M. Rubinstein, Elizabeth Wulff‐Burchfield, Rachel Rosovsky +45 more

Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2023.10.002

N/A

0DataRank · unranked

12 citations

Ajay K. Gopal, Brian G. Till, Mazyar Shadman, Ryan C. Lynch, Andrew J. Cowan +10 more